Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 system: Comparison with results obtained with the Vitek-2 and phoenix systems

Journal of Clinical Microbiology

Volumn 41, Issue 10, 2003, Pages 4823-4825

  Tang, Patrick ^a   Low, Donald E ^a   Atkinson, Sandra ^a   Pike, Karen ^a   Ashi Sulaiman, Aisha ^a   Simor, Andrew ^b   Richardson, Susan ^c   Willey, Barbara M ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; STREPTOGRAMIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; COMPUTER PROGRAM; CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; REAGENT KITS, DIAGNOSTIC; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PHOENIX; POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0141889172     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.10.4823-4825.2003     Document Type: Article

References (12)

1. Drinkovic, D., E. R. Fuller, K. P. Shore, D. J. Holland, and R. Ellis-Pegler. 2001. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J. Antimicrob. Chemother. 48:315-316.
2. Eady, E. A., J. I. Ross, and J. H. Cove. 1990. Multiple mechanisms of erythromycin resistance. J. Antimicrob. Chemother. 26:461-465.
3. Goldman, R. C., and J. O. Capobianco. 1990. Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. Antimicrob. Agents Chemother. 34:1973-1980.
4. Hamilton-Miller, J. M., and S. Shah. 2000. Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J. Antimicrob. Chemother. 46:941-949.
5. Jenssen, W. D., S. Thakker-Varia, D. T. Dubin, and M. P. Weinstein. 1987. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob. Agents Chemother. 31:883-888.
6. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
7. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272. (Erratum, 35:2165.)
8. Leclercq, R., and P. Courvalin. 1991. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob. Agents Chemother. 35:1273-1276.
9. Quality Management Program-Laboratory Services, Ontario Medical Association. 2001. Committee comments survey B-0106-2, vol. 3, p. 651-652. Ontario Medical Association, Ontario, Canada.
10. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
11. Sanchez, M. L., K. K. Flint, and R. N. Jones. 1993. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem? Diagn. Microbiol. Infect. Dis. 16:205-213.
12. Watanakunakorn, C. 1976. Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. Am. J. Med. 60:419-425.